Patent Assignment
Reel/Frame 063362/0550
Release of Grant of Security Interest in Patents
Recorded: 2023-04-18
Pages: 73
Assignor
ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Executed: 2023-04-17
Assignee
BIOCRYST PHARMACEUTICALS, INC.
4505 EMPEROR BLVD, DURHAM, NORTH CAROLINA, 27703
Covered Properties
(74)
Crystalline Salts of a Plasma Kallikrein Inhibitor
PCT:
PCT/US2019/059385 ↗
Plasma Kallikrein Inhibitors and Methods of Use Thereof in Ocular Disorders
PCT:
PCT/US2020/027287 ↗
Dosing Regimens for Oral Complement Factor D Inhibitors
PCT:
PCT/US2020/044037 ↗
Process-Scale Synthesis of a Plasma Kallikrein Inhibitor
PCT:
PCT/US2020/044921 ↗
Oral Complement Factor D Inhibitors
PCT:
PCT/US2020/054922 ↗
Oral Complement Factor D Inhibitors
PCT:
PCT/US2020/054992 ↗
Inhibitors of Nucleoside Metabolism
Patent:
5,985,848 →
Application:
08/949,388 →
Inhibitors of Nucleoside Metabolism
Patent:
6,066,722 →
Application:
09/172,321 →
Inhibitors of nucleoside metabolism
Patent:
6,228,847 →
Application:
09/496,741 →
Substituted Cyclopentane and Cyclopentene Compounds Useful as Neuraminidase Inhibitors
Patent:
6,562,861 →
Application:
09/555,131 →
Inhibitors of Nucleoside Metabolism
Cyclopentane and Cyclopentene Compounds and Use for Detecting Influenza Virus
Patent:
6,503,745 →
Application:
09/831,140 →
Deazaguanine Analog, Preparation Thereof and Use Thereof
Patent:
6,458,799 →
Application:
09/847,998 →
Process for Preparing 2-Pyrrolidinyl-1H-Pyrrolo[3,2-D]Pyrimidine Inhibitors of Nucleoside Metabolism
Patent:
6,693,193 →
Application:
09/958,219 →
Process for Preparing Substituted Cyclopentane Derivatives and Novel Crystalline Structures Thereof
Inhibiting T-Cell Proliferation
Preparation of Substituted Cyclopentane and Cyclopentene Compounds and Certain Intermediates
Patent:
6,762,316 →
Application:
10/019,217 →
Process for Preparing (-)-(1S, 4R) N-Protected 4-Amino-2-Cyclopentene-1-Carboxylate Esters
Biaryl Compounds as Serine Protease Inhibitors
Patent:
6,699,994 →
Application:
10/127,460 →
Inhibitors of Nucleoside Metabolism
Preparation of Deazaguanine Analog
Patent:
6,780,993 →
Application:
10/367,950 →
Carboxy Pyrrole, Process of Preparing and Use as Precursor
5H-Pyrrolo[3,2-D] Pyrimidine Inhibitors of Nucleoside Phosphorylases and Nucleosidases
Process for Preparing Inhibitors of Nucleoside Metabolism
Biaryl Compounds as Serine Protease Inhibitors
Inhibitors of Nucleoside Metabolism
Aza Nucleosides, Preparation Thereof and Use as Inhibitors of Rna Viral Polymerases
Process for the Preparation of Substituted Pyrrolidine Derivatives and Intermediates
Nucleosides, Preparation Thereof and Use as Inhibitors of Rna Viral Polymerases
Process for Preparing Inhibitors of Nucleoside Metabolism
Therapeutic Furopyrimidines and Thienopyrimidines
Hepatitis C Therapies
Process for Preparing Inhibitors of Nucleoside Metabolism
Inhibitors of Nucleoside Metabolism
Methods for the Preparation of 9-Deazapurine Derivatives
Acyclic Amine Inhibitors of Nucleoside Phosphorylases and Hydrolases
Hepatitis C Therapies
Fused Pyrimidines as Inhibitors of Nucleoside Phosphorylases and Nucleosidases
Antiviral Nucleoside Analogs
Tetrahydrofuro [3,4-D] Dioxolane Compounds for Use in the Treatment of Viral Infections and Cancer
Antiviral Treatments
Useful Pharmaceutical Salts of 7- [(3R, 4R) - 3 - Hydroxy -4 - Hydroxymethyl - Pyrrolidin -1- Ylmethyl] -3, 5-Dihydro-Pyrrolo [3, 2-D] Pyrimidin -4-One
Antiviral Treatments
Compositions and Methods for Inhibiting Viral Polymerase
Methods and Compositions for Inhibition of Polymerase
Anti-Influenza Compositions and Methods
Human Plasma Kallikrein Inhibitors
Methods and Compositions for Inhibition of Polymerase
Compositions and Uses of Amidine Derivatives
Antiviral Treatments
Human Plasma Kallikrein Inhibitors
Human Plasma Kallikrein Inhibitors
Human Plasma Kallikrein Inhibitors
Methods and Compositions for Inhibition of Polymerase
Benzopyrazole Compounds and Analogues Thereof
Methods and Compositions for Treatment of Zika Virus Infection
Prodrugs of Kallikrein Inhibitors
Methods of Treating Hematologic Cancers
Human Plasma Kallikrein Inhibitors
Substituted Benzofuran, Benzopyrrole, Benzothiophene, and Structurally Related Complement Inhibitors
Antiviral Treatments
Methods and Compositions for Inhibition of Polymerase
Imidazole-Containing Inhibitors of ALK2 Kinase
Crystalline Salts of a Plasma Kallikrein Inhibitor
Methods and Compositions for Treatment of Zika Virus Infection
Human Plasma Kallikrein Inhibitors
Crystalline Salts of a Plasma Kallikrein Inhibitor
Human Plasma Kallikrein Inhibitors
Human Plasma Kallikrein Inhibitors
Human Plasma Kallikrein Inhibitors
Prodrugs of Kallikrein Inhibitors
Indole Compounds and Analogues Thereof
Pyrrolopyrimidine Amines as Complement Inhibitors
Application:
63/004,799 →
METHODS, COMPOSITIONS, AND DOSING REGIMENS FOR TREATMENT OF SARS-CoV-2 INFECTIONS
Application:
63/006,186 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License
Jun 25, 2012
From: YESHIVA UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028432/0990 →
Change of Name
Feb 26, 2015
From: INDUSTRIAL RESEARCH LIMITED
To: CALLAGHAN INNOVATION RESEARCH LIMITED
Reel/Frame 035101/0436 →
Assignment of Assignor's Interest
Mar 4, 2015
From: CALLAGHAN INNOVATION RESEARCH LIMITED
To: VICTORIA LINK LIMITED
Reel/Frame 035086/0004 →
Confirmatory License
Jun 15, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035841/0904 →
Assignment of Assignor's Interest
Oct 13, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036851/0595 →
Assignment of Assignor's Interest
Oct 13, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036851/0385 →
Assignment of Assignor's Interest
Oct 14, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036865/0901 →
Assignment of Assignor's Interest
Oct 14, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036855/0743 →
Assignment of Assignor's Interest
Oct 16, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036878/0001 →
Assignment of Assignor's Interest
Oct 16, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036877/0885 →
Change of Name
Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036888/0669 →
Change of Name
Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036887/0324 →
Change of Name
Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036888/0817 →
Change of Name
Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036887/0386 →
Change of Name
Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036887/0298 →
Change of Name
Oct 20, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036900/0216 →
Security Interest
Sep 26, 2016
From: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 039858/0967 →
Merger and Change of Name
Feb 26, 2019
From: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.; ALBERT EINSTEIN COLLEGE OF MEDICINE
To: ALBERT EINSTEIN COLLEGE OF MEDICINE
Reel/Frame 048438/0275 →
Confirmatory License
Apr 23, 2019
From: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 048976/0648 →
Assignment of Assignor's Interest
Dec 26, 2019
From: EL-KATTAN, YAHYA; BABU, YARLAGADDA S.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 051366/0520 →
Assignment of Assignor's Interest
Oct 26, 2020
From: EL-KATTAN, YAHYA; BABU, YARLAGADDA S.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 054164/0658 →
Assignment of Assignor's Interest
Oct 26, 2020
From: BABU, YARLAGADDA S.; SHERIDAN, WILLIAM P.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 054166/0224 →
Release of Security Interest
Dec 16, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
Reel/Frame 054774/0446 →
Security Interest
Dec 17, 2020
From: BIOCRYST PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Reel/Frame 054800/0634 →
Assignment of Assignor's Interest
Dec 30, 2020
From: KOTIAN, PRAVIN L.; BABU, YARLAGADDA S.; ZHANG, WEIHE; LU, PENG-CHENG
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 054777/0428 →